Location: Oslo, Norway
CIK: 0001475373 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 9, 2022
Total Value: $388M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 883,106 | $54.48M | 14.0% | $61.69 * | $54.57 | +2.2% | COM | 375558103 |
| BIIB | BIOGEN INC | 110,230 | $29.43M | 7.6% | $267.00 * | $267.48 | -20.6% | COM | 09062X103 |
| INCY | INCYTE CORP | 418,794 | $27.91M | 7.2% | $66.64 * | $73.93 | -0.1% | COM | 45337C102 |
| BMY | BRISTOL-MYERS SQUIBB CO | 353,627 | $25.14M | 6.5% | $71.09 * | $46.74 | +33.3% | COM | 110122108 |
| CAH | CARDINAL HEALTH INC | 358,700 | $23.92M | 6.2% | $66.68 * | $47.94 | +23.6% | COM | 14149Y108 |
| MRK | MERCK & CO INC | 253,159 | $21.8M | 5.6% | $86.12 * | $66.44 | +21.0% | COM | 58933Y105 |
| MDT | MEDTRONIC PLC | 269,957 | $21.8M | 5.6% | $80.75 | $86.14 | -6.2% | SHS | G5960L103 |
| ELV | ELEVANCE HEALTH INC | 46,032 | $20.91M | 5.4% | $454.25 | $305.13 | +49.2% | COM | 036752103 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 166,080 | $17.36M | 4.5% | $104.55 | $113.96 | -6.6% | COM | 98956P102 |
| CNC | CENTENE CORP DEL | 201,555 | $15.68M | 4.0% | $77.81 * | $66.44 | +34.5% | COM | 15135B101 |
| BSX | BOSTON SCIENTIFIC CORP | 387,184 | $15M | 3.9% | $38.73 * | $31.53 | +27.2% | COM | 101137107 |
| CI | CIGNA CORP NEW | 50,517 | $14.02M | 3.6% | $277.47 * | $207.88 | +27.4% | COM | 125523100 |
| BRKR | BRUKER CORP | 237,958 | $12.63M | 3.3% | $53.06 * | $52.55 | +12.3% | COM | 116794108 |
| — | SEAGEN INC | 84,730 | $11.59M | 3.0% | $136.83 | $160.88 | — | COM | 81181C104 |
| — | NUVASIVE INC | 248,649 | $10.89M | 2.8% | $43.81 | $56.60 | — | COM | 670704105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 109,604 | $9.291M | 2.4% | $84.77 * | $82.10 | +8.5% | COM | 09061G101 |
| BAX | BAXTER INTL INC | 169,028 | $9.104M | 2.3% | $53.86 * | $55.31 | 0.0% | COM | 071813109 |
| — | QIAGEN NV | 204,074 | $8.424M | 2.2% | $41.28 | $49.87 | — | SHS NEW | N72482123 |
| IONS | IONIS PHARMACEUTICALS INC | 164,223 | $7.264M | 1.9% | $44.23 * | $54.18 | -22.2% | COM | 462222100 |
| BIO | BIO RAD LABS INC | 11,988 | $5.001M | 1.3% | $417.17 * | $208.82 | +138.8% | CL A | 090572207 |
| — | SAGE THERAPEUTICS INC | 115,696 | $4.531M | 1.2% | $39.16 | $51.01 | — | COM | 78667J108 |
| PTCT | PTC THERAPEUTICS INC | 86,692 | $4.352M | 1.1% | $50.20 * | $38.55 | +27.1% | COM | 69366J200 |
| CVS | CVS HEALTH CORP | 43,443 | $4.143M | 1.1% | $95.37 * | $57.80 | +51.6% | COM | 126650100 |
| — | INTRA-CELLULAR THERAPIES INC | 68,612 | $3.193M | 0.8% | $46.54 | $61.19 | — | COM | 46116X101 |
| UHS | UNIVERSAL HLTH SVCS INC | 27,077 | $2.388M | 0.6% | $88.19 * | $139.48 | -27.2% | CL B | 913903100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 45,520 | $1.885M | 0.5% | $41.41 * | $69.58 | -26.1% | COM | 90400D108 |
| VIR | VIR BIOTECHNOLOGY INC | 89,808 | $1.731M | 0.4% | $19.27 * | $31.74 | -19.9% | COM | 92764N102 |
| — | RIGEL PHARMACEUTICALS INC | 1,346,904 | $1.589M | 0.4% | $1.18 | $2.78 | — | COM NEW | 766559603 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 6,921 | $1.385M | 0.4% | $200.12 * | $152.35 | +25.2% | COM | 02043Q107 |
| NVAX | NOVAVAX INC | 56,735 | $1.033M | 0.3% | $18.21 * | $98.47 | -56.0% | COM NEW | 670002401 |
| EMBC | EMBECTA CORP | 5,246 | $151K | 0.0% | $28.78 * | $25.42 | +2.9% | COMMON STOCK | 29082K105 |